About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sign up to stay informed--receive email notifications for this journal

3D Printing and Additive Manufacturing

Editor-in-Chief: Hod Lipson, PhD

ISSN: 2329-7662 • Published Quarterly • Online ISSN: 2329-7670

Current Volume: 1

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions


    Please follow all instructions carefully.  Noncompliance may result in your manuscript being returned to you to be modified to the Journal style before entering the review process.

    Create an Account in Manuscript Central

    If you do not already have an account in Manuscript Central (MC) for 3D Printing and Additive Manufacturing, you will need to create one.  The system will prompt you for required  information.  Once you create your account, you may log in to the system to begin your submission.  Manuscripts MUST be submitted online (only Word docs, not PDFs) using the following URL: http://mc.manuscriptcentral.com/3DP


    Use of English Language

    All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in 3D Printing and Additive Manufacturing.  For authors whose native language is not English, we suggest using a service that can aid in the translation and rewriting of material into correct and proper English usage.  The Publisher offers this service, with a subsidy from the author, prior to official submission (Contact AuthorServices@liebertpub.com for more information.)  It is important to note that employing the use of the Publisher’s service does not guarantee acceptance of any paper.  All submissions are subject to peer review.



    Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described as a footnote to the title. Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc.  By submitting a manuscript to the Journal, the author(s) agree(s) to each of these conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.



    All submissions will undergo a preliminary assessment by the Editorial Office.  Certain papers may be rejected without peer review if the Editor-in-Chief determines that the paper is out of the Journal’s scope.  All submissions to the Journal are subject to peer review.  Authors are encouraged, but not required, to supply the names and valid email addresses of three to four individuals who are considered qualified to review the submitted material, as well as the names of individuals whom the authors would prefer not be selected as a reviewer. However, the reviewer selection is ultimately at the discretion of the Editor.


    Authorship.  All authors, including the co-authors, should be responsible for a significant part of the manuscript.  All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content.   Any author whose name appears on a paper assumes responsibility and accountability for the results.

    Submitting Author/Agent:  It is incumbent upon the submitting author/agent  to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. Once a paper is accepted for publication, changes in authorship – including at the page proof stage – are NOT permitted.  Changes in authorship after publication are strictly prohibited.


    Corresponding Author:  It is the Journal’s policy that a manuscript has only ONE corresponding author listed on a paper.  This designation should be determined at the time of submission.  Additions to corresponding authors are not permitted after acceptance or in page proofs.  It is the corresponding author’s responsibility to share the page proofs with co-authors and to coordinate all authors’ corrections into one proof.  The Publisher will not accept corrections from multiple authors.




    Article Type

    Maximum Word Limit*

    Abstract Word Limit











    7,500 – 10,000





    Case Studies






    Short Reports


















    Letter to the Editor






    *These limits relate to the text of the manuscript; word limits do NOT include the abstract, figure and/or table legends, acknowledgments, disclosures, or references.


    Title page:

    The title page of your submission must be included as part of your main text document (not as a separate file) and must include the following items:

    • The complete title of the article

    • All contributing authors’ full names, complete affiliation(s) and mailing address(es), full contact information (telephone, fax, and valid e-mail address)

    • A brief running title (no more than 50 characters, including spaces)
    • The corresponding author’s complete contact information including address, working fax number, and e-mail address

    • A minimum of four keywords to assist in the peer-review process


    For all original and review papers, the next page of the manuscript should consist of an unstructured abstract of no more than 300 words, which should be self-explanatory without reference to the text. References are not permitted in the abstract.

    Requirements for Abstract:

    • Abstract should be no more than 300 words

    • Abstract should be unstructured
    • The use of the first person should be avoided

    • Clearly summarize the results and conclusions of the work

    • References are not permitted in the abstract

    • Do not use proprietary or trade names in the title or abstract


    Please provide a minimum of four keywords below the abstract.


    The text of the manuscript should follow this format: Abstract; Introduction; Materials and Methods; Results; Discussion; Conclusion(s), Acknowledgments; Author Disclosure Statement; and References. All manuscripts should be double-spaced.  For all material sources, such as devices, drugs, etc., indicate manufacturer/supplier name, city, state, and country.  If applicable, include trademark or registered symbols in the abstract at the first mention of a product and/or company name, and again at the first mention in the text. At the end of the manuscript, give the name and full address of the individual to whom correspondence should be directed.


    Tables should be prepared in Word.  Do not prepare them in PDFs, Excel, .TIFFs, or .EPS files.  Prepare tables double-spaced, one to a page and in a separate file from the text. Each table must stand alone, i.e., contain all necessary information in the table title and be understood independently of the text. Avoid repetition of information that is given in the text. Supply a title for each table.

    Figures and Legends:

    Figures must be submitted separately using the following guidelines:

    • Figure legends must be prepared in Word.

    • File names must be in English

    • Do NOT include any illustrations as part of your text file
    • Do NOT prepare any figures in Word, as they are not workable

    • Name figure files using only alphanumeric characters.  Do not use spaces, underscores, symbols, dots, or dashes
    • File names should be formatted with the first author’s name and figure number (Ex: SmithFig1)

    • Line illustrations must be submitted at 900 DPI

    • Halftones and color photos should be submitted at a minimum of 300 DPI

    • Save figures as either TIFF or EPS files

    • Color figures* must be saved as CYMK, not RGB

    • Do not include the legend on the figure

    • Figure legends must be prepared as an enumerated list as a separate file after the reference section.

    *The Journal will publish color figures, but the author must subsidize the cost. The Publisher will provide the author with a cost estimate when the figures are received if requested.



    The use of footnotes is generally discouraged, but can used only when essential.  Prepare footnotes double-spaced on a separate page.  Ensure that there are corresponding citations for footnotes within text.


    Collaborations, sources of research funds, and other acknowledgments should be listed in a separate section at the end of the text ahead of the References section.

    Author Disclosure Statement:

    Immediately following the Acknowledgments section, include a header entitled, “Author Disclosure Statement.” All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript.  Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultancies, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should also be disclosed in the Disclosure section.  If there are no conflicts to declare, the authors must state, “No conflicts of interest exist.”



    • All references must be cited in the text with superscript numbers, in numerical order, beginning with “1.” References must be typed double-spaced and numbered by order of citation.

    • List the first three names of authors, followed by et al.

    • Translate into English all foreign article and book titles.

    • If a work is in press, give the journal in which it is to be published, followed by “in press” in parentheses.

    • Page ranges should be inclusive (Ex:  721-729, not 721-9)

    • Unpublished Material: If a reference refers to unpublished data, a manuscript in preparation, or a manuscript submitted but not in press, it should be included in  parentheses in the body of the text, and not cited in the reference list.  Personal communications should be cited parenthetically in text only, and should not be included in the reference section.

    • Journal abbreviations should follow Medline style.


    Journal Articles:  Meseguer-Olmo L, Vicente-Oretga V, Alcaraz-Baños M, et al.  In-vivo behavior of Si-hydroxyapatite polycaprolactone/DMB scaffolds fabricated by 3D printing.  J Biomed Mater Res A 2013;101:2038-2048.

    Books:  Lipson H, Kurman M. Fabricated:  the new world of 3D printing. John Wiley & Sons, New York, NY, 2013.

    Chapter in a Book: Lipson H, Kurman M. Designing the future.  In: Fabricated:  the new world of 3D printing.  John Wiley & Sons, New York, NY, 2013; pp.241-261.

    • Please follow this structure, including capitalization and punctuation, for alternative types of references below:

    Websites:  List author/organization name (if available).  Article title.  Provide website site.  Include last accessed date.

    Conference Proceedings:  List all Authors’ (or) Editors’ names (last name first, followed by first and middle initials).  Conference title. Date of conference. Location of conference. City of publisher: Publisher; Year of publication. Complete number of pages in proceedings book.



    When submitting your REVISED manuscript after peer review, please be sure to follow the instructions for resubmission that will be provided in the email that contains the reviews of your paper.  Log on to Manuscript Central and go to your Author Center, and following the directions for resubmitting revisions.  If the deadline for submitting your revision has passed, please contact the Editorial Office or the Publisher to request an extension.  Please do NOT create a new submission for revised manuscripts. 

    Uploading manuscript REVISIONS after peer review: Please ensure that you have uploaded the following items for any revised manuscript:

    1. EACH REVISION must be submitted with the corrected document (only Word files, not PDFs) showing visible track changes as well as a clean document (without track changes).

    2. EACH REVISION should be COMPLETE with title page, author contact information, abstract, references, etc.  (Follow the same instructions as provided for original submissions.)

    3. ALL figures and tables are to be uploaded with EACH REVISION.



    Upon acceptance of any manuscript processed through Manuscript Central, all authors will receive a follow-up email with instructions on completing our online Copyright Agreement form.  Each author will receive individualized links to their copyright form.  Authors will not be permitted to “share” or forward these individualized links as they are unique to each author.  Therefore, it is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to ensure the proper delivery of each copyright form, and any other pertinent email communications.


    The corresponding author is responsible for communicating with coauthors to ensure they have completed the online copyright form. Authors not permitted to release copyright must contact the Journal in writing explaining the reason(s) for not releasing the copyright.

    Failure by any author(s) listed on a paper to submit this form WILL result in a delay in publication.  An accepted paper will not be released to production without the receipt of all copyright forms.



    The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher (not the author or editor) of publication concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, the first footnote of a reprinted table, or the last sentence of the legend of a reprinted figure, should read “Reprinted by permission from Ref. xx.” and list the appropriate reference number. All permission listings must be provided at the time of submission.


    If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients.  The submitting author should provide written confirmation of this critical information.  Acceptable forms of consent statements are emails or letters.  The Journal does not provide a generic patient release form.

    The written consent must contain specific information about the patient's name, age, and if pertinent, conservatorship -- as well as stated permission -- granting the Journal the rights to publish the photograph within its pages (which includes the name of the Journal and article title). 



    Page proofs will be sent to the (one) corresponding author as designated when the manuscript was uploaded to Manuscript Central.  It is the corresponding author’s responsibility to share the page proofs with co-authors and to coordinate all authors’ corrections into one proof.  The Publisher will not accept corrections from multiple authors. Changes in authorship in page proofs are NOT permitted under any circumstance.



    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.



    The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone:  914-740-2100; Fax:  914-740-2108; Email: info@liebertpub.com;  Website: www.liebertpub.com

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




Recommended Publications

You may be interested in the following publications:

    Tissue Engineering, Parts A, B, & C

    Tissue Engineering, Parts A, B, & C

    The preeminent, biomedical journal bringing together the principles of engineering and life sciences to advance the field with cutting-edge research and applications on all aspects of tissue growth and regeneration.

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.

    Soft Robotics

    Soft Robotics

    A multidisciplinary, peer-reviewed journal dedicated to the science and engineering of soft materials in mobile machines.

    Big Data

    Big Data

    This highly innovative, peer-reviewed journal, provides a unique forum for world-class research exploring the challenges and opportunities surrounding the growing field data science.

    Genetic Engineering & Biotechnology News

    Genetic Engineering & Biotechnology News

    The mostly widely-read publication covering tools, techniques, and technologies in the biotechnology industry.

Browse All Publications »

Watch a new video from Editor-in-Chief, Hod Lipson!